AKTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Akari Therapeutics Plc (AKTX).


$30.21M Market Cap.

As of 04/16/2025 5:00 PM ET (MRY) • Disclaimer

AKTX Market Cap. (MRY)


AKTX Shares Outstanding (MRY)


AKTX Assets (MRY)


Total Assets

$50.56M

Total Liabilities

$28.33M

Total Investments

$0

AKTX Income (MRY)


Revenue

$0

Net Income

-$19.79M

Operating Expense

$21.64M

AKTX Cash Flow (MRY)


CF Operations

-$12.55M

CF Investing

$382.00K

CF Financing

$10.99M

AKTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

-

-

2023

$0

0%

0%

-

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

-

-

2020

$0

0%

-

0%

-

AKTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$50,562,000 (1061.01%)

$4,355,000 (-68.51%)

$13,831,612 (18.75%)

$11,648,028 (-20.25%)

Assets Current

$2,952,000 (-32.00%)

$4,341,000 (-68.58%)

$13,814,732 (18.84%)

$11,625,099 (-20.25%)

Assets Non-Current

$47,610,000 (339971.43%)

$14,000 (-17.06%)

$16,880 (-26.38%)

$22,929 (-15.55%)

Goodwill & Intangible Assets

$47,610,000 (339971.43%)

$14,000 (-17.06%)

$16,880 (-26.38%)

$22,929 (-15.55%)

Shareholders Equity

$22,229,000 (9806.99%)

-$229,000 (-112.79%)

$1,790,746 (-67.76%)

$5,554,582 (-40.81%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$2,659,000 (-30.85%)

$3,845,000 (-70.98%)

$13,249,945 (41.54%)

$9,361,270 (-33.40%)

Accumulated Other Comprehensive Income

-$738,000 (29.04%)

-$1,040,000 (-34.92%)

-$770,839 (-42.49%)

-$540,967 (16.53%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$12,407,000 (642.49%)

$1,671,000 (76.52%)

$946,658 (-47.07%)

$1,788,563 (-47.10%)

Accumulated Retained Earnings (Deficit)

-$247,252,000 (-8.70%)

-$227,461,000 (-4.60%)

-$217,453,110 (-8.89%)

-$199,705,048 (-9.56%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$8,040,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,260,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Current

$3,260,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$28,333,000 (518.08%)

$4,584,000 (-61.93%)

$12,040,866 (97.60%)

$6,093,446 (16.72%)

Liabilities Current

$19,910,000 (334.34%)

$4,584,000 (-61.93%)

$12,040,866 (97.60%)

$6,093,446 (16.72%)

Liabilities Non-Current

$8,423,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

AKTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,664,000 (-14.90%)

$11,356,000 (-16.05%)

$13,527,311 (67.40%)

$8,080,681 (-11.79%)

Research & Development Expense

$6,983,000 (28.13%)

$5,450,000 (-43.00%)

$9,560,897 (4.68%)

$9,133,455 (3.55%)

Operating Expenses

$21,643,000 (28.78%)

$16,806,000 (-27.21%)

$23,088,208 (34.12%)

$17,214,136 (-4.26%)

Interest Expense

$244,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$19,791,000 (-97.75%)

-$10,008,000 (43.61%)

-$17,748,062 (-1.86%)

-$17,424,237 (-2.01%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$19,791,000 (-97.75%)

-$10,008,000 (43.61%)

-$17,748,062 (-1.86%)

-$17,424,237 (-2.01%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$19,791,000 (-97.75%)

-$10,008,000 (43.61%)

-$17,748,062 (-1.86%)

-$17,424,237 (-2.01%)

Weighted Average Shares

$23,888,010,485 (144.03%)

$9,788,980,193 (56.79%)

$6,243,462,410 (45.46%)

$4,292,112,667 (35.87%)

Weighted Average Shares Diluted

$23,888,010,485 (144.03%)

$9,788,980,193 (56.79%)

$6,243,462,410 (45.46%)

$4,292,112,667 (35.87%)

Earning Before Interest & Taxes (EBIT)

-$19,547,000 (-95.31%)

-$10,008,000 (43.61%)

-$17,748,062 (-1.86%)

-$17,424,237 (-2.01%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$21,643,000 (-28.78%)

-$16,806,000 (27.21%)

-$23,088,208 (-34.12%)

-$17,214,136 (4.26%)

AKTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$382,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$10,988,000 (56.52%)

$7,020,000 (-72.24%)

$25,288,109 (76.93%)

$14,292,753 (-43.00%)

Net Cash Flow from Operations

-$12,552,000 (23.61%)

-$16,432,000 (23.59%)

-$21,504,522 (-14.10%)

-$18,846,528 (-11.19%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,186,000 (87.39%)

-$9,405,000 (-341.86%)

$3,888,675 (182.83%)

-$4,694,507 (-156.40%)

Net Cash Flow - Business Acquisitions and Disposals

$382,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$855,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$11,843,000 (68.70%)

$7,020,000 (-72.24%)

$25,288,109 (76.93%)

$14,292,753 (-43.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$4,000 (-157.14%)

$7,000 (-93.34%)

$105,088 (174.67%)

-$140,732 (-170.18%)

Share Based Compensation

$2,245,000 (95.22%)

$1,150,000 (56.44%)

$735,107 (133.63%)

$314,650 (-3.34%)

Depreciation Amortization & Accretion

$14,000 (250.00%)

$4,000 (7.87%)

$3,708 (-10.13%)

$4,126 (-53.68%)

AKTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-956.20% (25.38%)

-1281.40% (-165.19%)

-483.20% (-55.57%)

-310.60% (11.84%)

Return on Average Assets (ROAA)

-129.50% (-17.62%)

-110.10% (20.96%)

-139.30% (21.96%)

-178.50% (-37.73%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

216.90% (68.66%)

128.60% (-44.55%)

231.90% (-63.83%)

641.20% (159.49%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-

-

-

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.36 (101.97%)

-68.96 (-542.79%)

15.57 (21.15%)

12.85 (92.54%)

Debt to Equity Ratio (D/E)

1.27 (106.37%)

-20.02 (-397.69%)

6.72 (512.94%)

1.1 (97.30%)

Earnings Per Share (EPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.05 (68.69%)

-3.36 (51.27%)

-6.89 (21.56%)

-8.78 (18.16%)

Book Value Per Share (BVPS)

1.86 (4059.57%)

-0.05 (-108.19%)

0.57 (-77.82%)

2.59 (-56.44%)

Tangible Assets Book Value Per Share (TABVPS)

0.25 (-72.15%)

0.89 (-79.95%)

4.42 (-18.31%)

5.42 (-41.30%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (0.00%)

-1 (66.67%)

-3 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.48 (-72.24%)

-0.86 (22.57%)

-1.11 (66.61%)

-3.33 (-12.96%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.15 (-84.37%)

0.95 (-17.44%)

1.15 (-39.88%)

1.91 (-31.66%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$12,552,000 (23.61%)

-$16,432,000 (23.59%)

-$21,504,522 (-14.10%)

-$18,846,528 (-11.19%)

Enterprise Value (EV)

$28,959,440 (236.34%)

$8,610,134 (-56.38%)

$19,736,999 (-65.97%)

$58,004,990 (15.24%)

Earnings Before Tax (EBT)

-$19,791,000 (-97.75%)

-$10,008,000 (43.61%)

-$17,748,062 (-1.86%)

-$17,424,237 (-2.01%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$19,533,000 (-95.25%)

-$10,004,000 (43.62%)

-$17,744,354 (-1.86%)

-$17,420,111 (-2.03%)

Invested Capital

-$16,357,000 (-300.12%)

-$4,088,000 (64.38%)

-$11,476,079 (-199.67%)

-$3,829,617 (18.49%)

Working Capital

-$16,958,000 (-6878.60%)

-$243,000 (-113.70%)

$1,773,866 (-67.93%)

$5,531,653 (-40.88%)

Tangible Asset Value

$2,952,000 (-32.00%)

$4,341,000 (-68.58%)

$13,814,732 (18.84%)

$11,625,099 (-20.25%)

Market Capitalization

$30,205,440 (91.28%)

$15,790,822 (-43.38%)

$27,888,176 (-60.94%)

$71,395,979 (13.96%)

Average Equity

$2,069,750 (165.01%)

$781,000 (-78.73%)

$3,672,664 (-34.54%)

$5,610,519 (15.70%)

Average Assets

$15,286,000 (68.10%)

$9,093,500 (-28.62%)

$12,739,820 (30.54%)

$9,758,969 (-25.96%)

Invested Capital Average

-$9,010,000 (-15.78%)

-$7,782,000 (-1.69%)

-$7,652,848 (-181.64%)

-$2,717,239 (60.69%)

Shares

49,517,115,523 (389.19%)

10,122,321,523 (70.56%)

5,934,917,123 (24.69%)

4,759,731,923 (40.55%)